Point-of-Care/Rapid Diagnostics Market to Grow 10% CAGR and Projected to US$ 38.13 Billion by 2022, Led by Glucose, Hematology and Influenza

Share this news:

Geographically, point-of-care diagnostics market is divided into North America, Europe, Asia Pacific, & RoW. Asia Pacific is likely to record maximum growth rate during forecast period owing to increasing ingenuities by companies, snowballing patient population pool.

-- The point-of-care diagnostics market on the basis of product, platform, mode, end user, and region. Report also comprehends factors affecting market growth; it examines prospects and challenges in market and offers particulars of competitive landscape for market leaders. Report also forecasts the profits of market segments with respect to four key regions and respective countries. Report will augment both reputable firms as well as new entrants to test pulse of market, which, in turn, will help them harvest greater market shares.

Access Sample Papers of Point-of-Care Diagnostics Market spread across 226 Pages, Profiling 15 Companies and Supported with 129 Tables and 36 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1352500 .

The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period. Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally.

Premium Insights
1 POC Diagnostics: Market Overview
2 POC Diagnostics Market, By Platform
3 Geographic Analysis: POC Diagnostics Market, By End User and Region
4 POC Diagnostics Market, By Product
5 POC Diagnostics Market, By Prescription Mode
6 Geographic Snapshot of the POC Diagnostics Market

Point-fo-care diagnostics market segmented into lateral flow assays, dipsticks, micro fluidics, molecular diagnostics, and immunoassays. Molecular diagnostics segment expected to be fastest-growing segment during forecast period. Growing advancements in technology and increasing initiatives of market players for developing POC molecular diagnostic products is propelling the demand for molecular diagnostics.

Click Here for More Information on Point-of-Care Diagnostics Market with Top Trends and Global Forecast at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1352500 .

Geographically, the point-of-care diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.

Global Rapid Diagnostic Market, by Product
• Glucose Monitoring Products
• Cardiometabolic Testing Products
• Infectious Disease Testing Products
• Coagulation Testing Products
• Pregnancy & Fertility Testing Products
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drugs-of-Abuse Testing Products
• Fecal Occult Testing Products

Major players of point-of-care diagnostics market are Abbott (US), Roche (Switzerland), Siemens (Germany), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio (US), Sekisui Diagnostics (US), Nova (US), EKF Diagnostics (UK), Accu BioTech (China), and Trinity Biotech (US).

Click now for more information on this research of “Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022” report at http://www.reportsnreports.com/contacts/discount.aspx?name=1352500 .

Point-of-care Diagnostics Market based on product, platform, mode, end user, and region. The report also studies factors affecting market growth; it analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. The report forecasts the revenue of market segments with respect to the four key regions and respective countries.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Contact Info:
Name: Mr. Hrishikesh
Email: Send Email
Organization: ReportsandReports
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India
Phone: +1 888 391 5441
Website: http://www.reportsnreports.com/reports/1352500-point-of-care-rapid-diagnostics-market-by-testing-glucose-lipids-hba1c-hcv-hiv-influenza-urinalysis-hematology-cancer-pregnancy-pt-inr-platform-lateral-flow-immunoassay-mode-prescription-otc-end-st-to-2022.html

Release ID: 342679

CONTACT ISSUER
SUBSCRIBE FOR MORE